Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Gastroenterology

Are Daily Acid Reflux Pills (PPIs) Safe to Take Long-Term?

At a Glance

Long-term PPIs are generally well tolerated when GERD treatment is medically necessary. Uncommon concerns include low magnesium, kidney inflammation, gut infections, and drug interactions, while current evidence does not show a clear dementia risk. Use the lowest effective dose with guidance.

Yes, when there is a clear medical need, long-term use of proton pump inhibitors (PPIs) is generally well-tolerated. Clinical guidelines from the American College of Gastroenterology (ACG) state that the proven benefits of healing severe acid damage outweigh the risks [1]. However, no medication is entirely risk-free. If your GERD is uncomplicated and your symptoms have resolved, your doctor will likely aim to use the lowest effective dose or eventually stop the medication entirely [1][2].

For certain conditions, the benefits of long-term acid suppression are clear. If you have Barrett’s esophagus (a precancerous change in the esophagus lining) or severe erosive esophagitis, daily PPI treatment is generally recommended and usually maintained indefinitely to protect your esophagus [1][3]. However, taking a PPI does not completely eliminate cancer risk, nor does it replace the need for routine endoscopic surveillance [1]. If you have these conditions, you should not stop your medication without consulting your doctor.

Known Side Effects and Warning Signs

While most people tolerate PPIs well, they can cause common side effects such as headache, nausea, abdominal discomfort, diarrhea, or constipation [1].

Though uncommon, there are recognized risks associated with long-term use, including low magnesium levels, acute kidney inflammation, an increased risk of intestinal infections (which can cause severe watery diarrhea), and specific medication interactions [1][4].

When to Seek Immediate Care:
Reassurance about long-term PPI safety should not delay evaluation of “alarm” symptoms. Seek prompt medical attention if you experience:

  • Difficulty or pain with swallowing
  • Food getting stuck in your chest
  • Vomiting blood or passing black, tarry stools
  • Unexplained weight loss or persistent vomiting
  • Severe or new chest pain (which should be treated as a medical emergency, as it could be heart-related)

Addressing the Rumors: Dementia and Bone Fractures

Patients often see alarming headlines about long-term PPI harms, but these often stem from observational studies that show two things are associated, rather than proving the medication caused the problem [5].

  • Dementia: While some older studies suggested a link between PPIs and dementia [6], the best current evidence is reassuring. A 2025 review of over 6.3 million people found no statistically significant increase in dementia risk among PPI users [7]. Similarly, large 10-year tracking studies of older adults found no association between taking PPIs and developing cognitive decline [8][9]. You should not stop a necessary PPI out of fear of dementia.
  • Bone Fractures: Research shows a modest association between PPI use and bone fractures [10]. However, most studies that actually measure bone mineral density (BMD) (the amount of minerals in your bones) do not show a clinically important difference or bone loss caused directly by the medication [10][11]. Because the research doesn’t prove PPIs directly weaken bones, the recommendation is to use the lowest effective dose for your symptoms rather than avoid the drug entirely [2].

Do I Need Special Testing or Supplements?

The American Gastroenterological Association (AGA) advises against routinely checking bone density or testing levels of magnesium, calcium, or vitamin B12 just because you take a PPI [2]. They also do not recommend taking extra supplements beyond standard daily dietary allowances [2][12].

However, monitoring and supplements are appropriate if you have other risk factors, such as a history of osteoporosis, kidney disease, poor nutrition, or if you take other medications that affect magnesium (like certain diuretics) [2][12][4].

How to Safely Reduce Your Dose

If your clinician confirms you do not have a continuing high-risk indication (like Barrett’s esophagus), you may be a candidate for deprescribing. Doctors may recommend either stopping abruptly or a gradual tapering schedule [13].

Stopping a PPI can cause rebound acid hypersecretion—a temporary surge of stomach acid that makes it feel like your GERD has returned [1][13]. This rebound is usually temporary and does not necessarily mean your underlying disease is getting worse. Flare-ups during this time can often be managed with clinician-approved rescue options like antacids or H2 blockers [13].

Common questions in this guide

Are proton pump inhibitors safe to take for GERD over many years?
Generally, PPIs are well tolerated when there is a clear medical reason for long-term treatment. Their benefits are especially important for people with severe esophageal inflammation or Barrett's esophagus. If GERD is uncomplicated and controlled, a clinician may try the lowest effective dose or stopping.
Which people may need to stay on a PPI indefinitely?
People with Barrett's esophagus or severe erosive esophagitis are often advised to continue daily PPI therapy to protect the esophagus. A PPI does not remove cancer risk or replace endoscopic surveillance for Barrett's. Do not stop it without discussing it with your doctor.
What side effects and serious risks can long-term PPIs cause?
Common side effects include headache, nausea, abdominal discomfort, diarrhea, and constipation. Uncommon but recognized risks include low magnesium, kidney inflammation, intestinal infections that may cause severe watery diarrhea, and interactions with some medicines.
Do PPIs cause dementia or weak bones?
Current evidence does not show a statistically significant increase in dementia among PPI users, although earlier observational studies raised concern. Studies have found a modest association with fractures, but most studies measuring bone density do not show clinically important bone loss directly caused by PPIs. Do not stop necessary therapy based only on these concerns; discuss the dose with your clinician.
Do I need magnesium, vitamin B12, calcium, or bone-density tests because I take a PPI?
Routine bone-density scans or magnesium, calcium, and vitamin B12 tests are not recommended solely because someone takes a PPI. Monitoring or supplements may be appropriate with osteoporosis, kidney disease, poor nutrition, or medicines that affect magnesium, such as certain diuretics. A clinician can tailor monitoring to your other health risks.
How can I safely stop or reduce a PPI?
First confirm with your clinician that you do not have a condition requiring ongoing treatment, such as Barrett's esophagus or severe erosive esophagitis. Depending on why it was prescribed, your clinician may recommend stopping abruptly or tapering. Temporary rebound acid production can cause reflux-like symptoms, and clinician-approved antacids or H2 blockers may help.
What warning signs need prompt medical attention while taking a PPI?
Seek prompt medical attention for trouble or pain with swallowing, food getting stuck, vomiting blood, black or tarry stools, unexplained weight loss, or persistent vomiting. Severe or new chest pain should be treated as an emergency because it could be heart-related.

Get notified when new evidence is published on gastroesophageal reflux disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

    Katz PO, Dunbar KB, Schnoll-Sussman FH, et al.

    The American journal of gastroenterology 2022; (117(1)):27-56 doi:10.14309/ajg.0000000000001538.

    PMID: 34807007
  2. 2

    The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.

    Freedberg DE, Kim LS, Yang YX

    Gastroenterology 2017; (152(4)):706-715 doi:10.1053/j.gastro.2017.01.031.

    PMID: 28257716
  3. 3

    The management of gastro-oesophageal reflux disease.

    Keung C, Hebbard G

    Australian prescriber 2016; (39(1)):6-10 doi:10.18773/austprescr.2016.003.

    PMID: 27041798
  4. 4

    Proton pump inhibitor associated hypomagnasaemia - a cause for concern?

    Begley J, Smith T, Barnett K, et al.

    British journal of clinical pharmacology 2016; (81(4)):753-8 doi:10.1111/bcp.12846.

    PMID: 26613375
  5. 5

    Proton Pump Inhibitors: Review of Emerging Concerns.

    Nehra AK, Alexander JA, Loftus CG, Nehra V

    Mayo Clinic proceedings 2018; (93(2)):240-246 doi:10.1016/j.mayocp.2017.10.022.

    PMID: 29406201
  6. 6

    Regular proton pump inhibitor use and incident dementia: population-based cohort study.

    Zhang P, Li Z, Chen P, et al.

    BMC medicine 2022; (20(1)):271 doi:10.1186/s12916-022-02478-y.

    PMID: 36045363
  7. 7

    Inconsistency in the Association Between Proton Pump Inhibitor Use and Dementia Risk: An Updated Meta-Analysis.

    Peng TR, Lin HH, Yang LJ, Wu TW

    Brain sciences 2026; (16(2)) doi:10.3390/brainsci16020159.

    PMID: 41750160
  8. 8

    Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.

    Gray SL, Walker RL, Dublin S, et al.

    Journal of the American Geriatrics Society 2018; (66(2)):247-253 doi:10.1111/jgs.15073.

    PMID: 29134629
  9. 9

    Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study.

    Mehta RS, Kochar B, Zhou Z, et al.

    Gastroenterology 2023; (165(3)):564-572.e1 doi:10.1053/j.gastro.2023.05.052.

    PMID: 37315867
  10. 10

    Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis.

    Nassar Y, Richter S

    Journal of bone metabolism 2018; (25(3)):141-151 doi:10.11005/jbm.2018.25.3.141.

    PMID: 30237993
  11. 11

    Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.

    Hansen KE, Nieves JW, Nudurupati S, et al.

    Gastroenterology 2019; (156(4)):926-934.e6 doi:10.1053/j.gastro.2018.11.023.

    PMID: 30445008
  12. 12

    Drug-induced bone loss: a major safety concern in Europe.

    Nguyen KD, Bagheri B, Bagheri H

    Expert opinion on drug safety 2018; (17(10)):1005-1014 doi:10.1080/14740338.2018.1524868.

    PMID: 30222369
  13. 13

    Deprescribing proton pump inhibitors.

    Turner JP, Thompson W, Reeve E, Bell JS

    Australian journal of general practice 2022; (51(11)):845-848 doi:10.31128/AJGP-07-22-6497.

    PMID: 36310001

This page is for informational purposes only and does not constitute medical advice. Ask your clinician before changing or stopping a PPI for GERD.